| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58.3M | — | +104.4% |
| Cost of Revenue | $12.0M | — | +222.1% |
| Gross Profit | $46.3M | — | +86.8% |
| R&D Expense | $7.8M | — | -15.4% |
| SG&A Expense | $54.0M | — | -42.8% |
| Operating Income | -$15.5M | — | +80.4% |
| Net Income | -$30.4M | — | +67.8% |
| EPS (Basic) | -$0.37 | — | +71.8% |
| EPS (Diluted) | -$0.37 | — | +71.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $180.9M | +39.2% | -14.8% |
| Accounts Receivable | $80.7M | +3.3% | +122.0% |
| Inventory | $6.5M | +17.9% | +105.6% |
| Current Assets | $276.6M | +20.8% | +4.4% |
| Total Assets | $305.1M | +17.7% | +3.7% |
| Current Liabilities | $125.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.6M | — | +81.6% |
| Capital Expenditures | $61K | — | +238.9% |
| Investing Cash Flow | -$61K | — | -238.9% |
| Financing Cash Flow | $66.6M | — | — |
| Free Cash Flow | -$15.7M | — | +81.5% |
| +68.9% |
| Long-term Debt | $163.7M | -21.7% | -19.5% |
| Total Liabilities | $642.1M | -7.9% | +1.5% |
| Stockholders' Equity | -$337.0M | +23.1% | +0.4% |